OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Improving Aseptic Processing and Manufacturing Needs
Laboratories are focusing on more automated processes while also trying to maintain quality with each analytical test.
Quality Quartets may be used to achieve knowledge-driven, risk-based approaches to commissioning and qualification that are consistent with ICH Q9(R1) principles.
The biggest hurdle is developing palatable formulations that are efficacious and patient friendly.
A comprehensive understanding of what makes mRNA vaccines tick is crucial in charting the future of the market.
Interoperability difficulties resulting from discrepancies in preferred programming languages can be resolved via statistical computing environments.
mRNA Past, Present, and Future
October 02, 2023
The newly established business under Advent International and Warburg Pincus will be named Simtra BioPharma Solutions.
Government provides a spoonful of sugar, and genuine leadership, for good medicines.
September 29, 2023
Under the partnership, Sartorius will leverage SPARTA Biodiscovery’s technology to accelerate development of nanoparticles used for drug delivery.
The contract is part of US Department of Health and Human Services’ ‘Project NextGen’ initiative, aimed at pushing forward new and stronger COVID-19 vaccines and therapies.
Dosage forms are being shaped by numerous factors, with patient-centricity continuing to be an important driver of decisions in development.
A control strategy can function as a powerful “hub” to gain a comprehensive understanding of the consolidated set of controls that are necessary to ensure consistent delivery of quality product.
Twin-screw granulation process insight is growing as researchers employ new analytical technologies and investigate new ways to use the equipment.
September 28, 2023
With the two new GMP-grade mRNA manufacturing sites in Germany, MilliporeSigma can now offer fully integrated mRNA services.
Consistent growth in outsourced biomanufacturing points to an evolving industry increasingly reliant on external capacity and expertise.
Sustainability advances are being made, but more investment is needed.